Talking Precision Medicine - Genialis

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.genialis.com/category/news/
7 partages
https://www.genialis.com/krasid/
4 partages
https://www.genialis.com/2025/01/08/tempus-announces-a-collaboration-with-genialis-to-develop-rna-based-biomarker-algorithms/
2 partages

https://www.linkedin.com/company/genialis
3 partages
https://www.linkedin.com/in/ryanfukushima/
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Zola-007: Giving T-cells the license to kill | Talking Precision Medicine #38

Saison 7 · Épisode 4

jeudi 29 août 2024 • Durée 44:06

What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game.

Episode 38 links:

Lire plusRéduire

Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37

Saison 7 · Épisode 3

lundi 22 juillet 2024 • Durée 39:01

In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem.

Episode 37 links:

Lire plusRéduire

A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28

Saison 5 · Épisode 3

mercredi 30 novembre 2022 • Durée 45:36

In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.

Visit TPM E28 for highlights and links from this episode.

Lire plusRéduire

What’s in a Name?: Endpoint Health’s Patient-Centric Northstar | Talking Precision Medicine #27

Saison 5 · Épisode 2

lundi 27 juin 2022 • Durée 43:16

This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care.

Visit TPM E27 for highlights and links from this episode.

Lire plusRéduire

Taking charge of your health future with wearables and AI | Talking Precision Medicine #26

Saison 5 · Épisode 1

lundi 28 février 2022 • Durée 33:33

In this episode 26, our host Rafael sits down with Harry Glorikian. Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You, and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it.

Visit TPM E26 for highlights and links from this episode.

Lire plusRéduire

Real-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring | Talking Precision Medicine #25

Saison 4 · Épisode 6

dimanche 5 septembre 2021 • Durée 31:47

Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta, co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let’s get right to it.

Visit TPM 25 for highlights and links from this episode.

Lire plusRéduire

Fostering Patient Journeys Around the World | Talking Precision Medicine #24

Saison 4 · Épisode 5

mercredi 28 juillet 2021 • Durée 40:42

Our guest is Dr. Angeli Moeller, Head of Pharma International Informatics at Roche. Angeli and our host, Rafael, discuss data science in the big pharma leagues; geek out on data standards; and dive deep on patient data rights and barriers to care.

Visit TPM E24 for highlights and links from this episode.

Lire plusRéduire

From Cancer to Covid, Drug Intelligent Science at Breakneck Pace | Talking Precision Medicine #23

Saison 4 · Épisode 1

vendredi 26 février 2021 • Durée 47:19

Our guest for this episode of Talking Precision Medicine is Liang Schweizer from HiFiBiO Therapeutics - one of the most exciting young biotechs out there. They have built a discovery engine encompassing single cell, immune profiling and machine learning.

Visit TPM E23 for highlights and links from this episode.

Lire plusRéduire

Ethics and Policies of Precision Medicine on the Global Stage | Talking Precision Medicine #22

Saison 3 · Épisode 6

jeudi 19 novembre 2020 • Durée 49:32

Our guests for this episode of Talking Precision Medicine are Elissa Prichep and Cameron Fox of the World Economic Forum. Elissa and Cameron take us through the W.E.F’s precision medicine initiative, and explain how anticipating ethical tensions is key to envisioning policies for precision medicine across the globe.

Visit TPM E22 for highlights and links from this episode.

Lire plusRéduire

Rebooting generics to fight cancer | Talking Precision Medicine #21

Saison 3 · Épisode 5

lundi 31 août 2020 • Durée 51:12

Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman, COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz. Each one provides perspective on their part of the puzzle.

Visit TPM E21 for highlights and links from this episode.

Lire plusRéduire

Podcasts et contenus similaires

Autres podcasts ou contenus associés partageant des thèmes ou audiences similaires.

Talking Precision Medicine – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Liens partagés entre épisodes et podcasts

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Talking Precision Medicine – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Liens partagés entre épisodes et podcasts

Other92

LinkedIn15

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Other92

LinkedIn15

Apple Podcasts

Goodreads4

Spotify